Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Teijin
Teijin
Activities:
Cardiovascular
Bone & Joint Health
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Research & Development
Teijin and Axcelead to determine the name of drug discovery research venture
Axcelead TWP’s business will include supporting drug discovery-related activities from target selection to the discovery of candidate compounds and related research activities
Manufacturing
Teijin Frontier introduces new nonwoven microcarriers for speedy and large-scale cell culture
The new nonwoven microcarriers combine Teijin Frontier’s proprietary fibre process and nonwoven design technology and fibre-related bio-medical expertise by Professor Satoshi Fujita
Manufacturing
Teijin enters LoI for cell and gene therapies
The development of preferred clinical trial and regulatory pathways for the companies’ customers is also under discussion
Drug Delivery
Teijin and Axcelead's agreement on capital and business alliance
The new company will utilise Teijin's drug discovery research technologies, facilities, equipment and personnel
Research & Development
Teijin, J-TEC, Mitsui Fudosan and NCC establish regenerative medicine platform
The platform supports the development of innovative treatments for diseases with unmet needs such as cancer
Finance
Teijin Pharma and TransThera form strategic R&D collaboration
The two companies say they’re confident they can complement their respective strengths in small molecule drug discovery
Research & Development
Teijin signs agreement to research drugs for frailty in elderly people
Japanese pharma company eyes a gap in the market that will become increasingly imperative with the rising longevity in Japan
Subscribe now